Home » Authors » Omar Ford

Articles by Omar Ford

Simulation: unproven, costly but beginning to gain traction

Oct. 25, 2007

ExThera formed to treat sepsis as latest device/drug matchup

Oct. 22, 2007

Virtual Companies Project used to boost Michigan's economy

Oct. 16, 2007

In $42M buy, QLT has ForSight to address glaucoma patients

Oct. 10, 2007

Apollo in ‘A’ $11.5 million round; Simplex Diabetic garners $50M

Oct. 9, 2007

Panelist: ‘Focus’ essential for medical device start ups

Oct. 8, 2007

Med-tech landscape is sunny, but watch out for ‘storm clouds’

Oct. 5, 2007

Spectranetics launches PATENT trial for SFA instent restenosis

Oct. 3, 2007

Calcification attack, but adjacent tissue safety via Diamondback

Oct. 1, 2007

Product briefs: Digital Health wins PMA for Retasure retinopathy detection

Oct. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...